For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...

Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...

After up to three years on GA Depot, most people with PPMS have not experienced any disability progression, according to new ...

What are the often invisible cognitive consequences of multiple sclerosis? Maureen van Dam mapped these out during her ...

A collaborative team of researchers and students from Wayne State University's Eugene Applebaum College of Pharmacy and ...

Researchers have discovered a biomarker for Alzheimer's disease in the cerebrospinal fluid known as MTBR-tau243 can be used to track the progression of the disease and could speed drug development.

By Tarun Sai Lomte Blood-based DNA repair and stress-response signals reveal a brief molecular window preceding Parkinson’s ...

A woman in her 60s with a history of atrial fibrillation, hypertension and dyslipidaemia was admitted to the Intensive Care ...